The DOI matches its Crossref record; 102 of the 113 references it cites were found in a registry or an index; 10 of the 51 sources its claims cite were checked for support.
The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline
Open accessAbstract
Neurodegeneration, the progressive death of neurons, loss of brain function, and cognitive decline is an increasing problem for senior populations. Its causes are poorly understood and therapies are largely ineffective. Neurons, with high energy and oxygen requirements, are especially vulnerable to detrimental factors, including age-related dysregulation of biochemical pathways caused by altered expression of multiple genes. GHK (glycyl-l-histidyl-l-lysine) is a human copper-binding peptide with biological actions that appear to counter aging-associated diseases and conditions. GHK, which declines with age, has health promoting effects on many tissues such as chondrocytes, liver cells and human fibroblasts, improves wound healing and tissue regeneration (skin, hair follicles, stomach and intestinal linings, boney tissue), increases collagen, decorin, angiogenesis, and nerve outgrowth, possesses anti-oxidant, anti-inflammatory, anti-pain and anti-anxiety effects, increases cellular stemness and the secretion of trophic factors by mesenchymal stem cells. Studies using the Broad Institute Connectivity Map show that GHK peptide modulates expression of multiple genes, resetting pathological gene expression patterns back to health. GHK has been recommended as a treatment for metastatic cancer, Chronic Obstructive Lung Disease, inflammation, acute lung injury, activating stem cells, pain, and anxiety. Here, we present GHK's effects on gene expression relevant to the nervous system health and function.
Overview
CoChat Summary
TL;DR
This paper argues that the human copper-binding peptide GHK is associated with gene-expression changes relevant to nervous system function and cognitive decline, based on Connectivity Map data and prior biological studies. The authors report that GHK broadly shifts genes toward regeneration, antioxidant defense, DNA repair, and neuronal support, and propose it as a candidate for nerve-disease therapy.
Key findings
- Using the Broad Institute Connectivity Map, the authors report that 31.2% of human genes are stimulated or suppressed by GHK with a change of ≥50%. They also state that GHK affects over 700 human genes associated with various nerve cell types.
- For DNA repair, they report that GHK is “primarily stimulatory” with 47 genes up and 5 down; for the ubiquitin proteasome system, 41 genes increased and 1 gene suppressed.
- A manual search found 18 genes with significant antioxidant activity, and another search found 7 anti-pain genes increased and 2 decreased.
- The paper reports that GHK-related gene-expression effects were examined across categories including neurons, motor neurons, glial cells, astrocytes, Schwann cells, myelin, dendrites, oligodendrocytes, sensory nerve cells, and spinal nerve cells, but the excerpt does not give counts for those categories.
Methods
- The study is a bioinformatics / literature-review analysis of GHK’s effects on gene expression relevant to the nervous system, supplemented by previously reported in vivo and in vitro findings.
- Gene-expression data were obtained from the Connectivity Map (cMap): three GHK profiles at 1 micromolar from two PC3 (prostate cancer) profiles and one MCF7 (breast cancer) profile; the dataset used 22,277 probe sets representing 13,424 genes.
- Analysis was performed in GenePattern after MAS5 processing and background correction; fold changes were converted to percentages, averaged across probe sets, and then genes were searched manually or by Gene Ontology terms such as “neuron,” “glial,” “astrocyte,” “Schwann,” “myelin,” “dendrite,” “oligodendrocyte,” “sensory,” and “spinal.”
Limitations
- The paper itself notes that gene-expression numbers can vary widely and are not always predictable; it gives NGF as an example where cMap suggested suppression (−243%) but other rat and cell-culture studies suggested increased nerve outgrowth.
- The text makes evident that much of the paper’s evidence is indirect: it relies heavily on cMap signatures, manual gene searches, and prior studies rather than new nervous-system experiments in humans or disease models specifically designed for this paper.
- The paper states that the minimum effective dosage is unknown and that dose-ranging studies “were never performed”; it also says the best administration method is only the authors’ opinion, indicating therapeutic recommendations are speculative.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Uptake of glycyl-l-histidyl-l-lysine (GHK) into various mouse tissues. (Reprinted from Pickart, L. [43]).](https://figures.cochat.ai/paper-figures/a819553d943f43dcba769ff7601c8e72/the-effect-of-the-human-peptide-ghk-on-gene-expression-relevant-to-nervous-figure-2.jpg)

Verification
Claims the paper makes
7 Valid · 3 Not valid · 23 Not checked · 11 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“GHK-Copper 2+ increased superoxide dismutase (SOD) activity in mice as detailed below in Section 4 [42].”
§ The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline > 3. Results > 3.2. Copper Deficiency, Dementia, and Nerve Dysfunction
What the sources say
- Supportedcites [42] Park, 2016, The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice, Oncotarget source
The Results section, “GHK-Cu increased antioxidant enzymes and decreased pro-inflammatory cytokines in LPS-induced ALI in mice” (page not provided), reports significantly higher SOD activity in LPS-treated mice given GHK-Cu than in mice given LPS alone. The finding is specific to the LPS-induced lung-injury model. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The use of GHK-Cu in mice protected their lung tissue from lipopolysaccharide-induced acute lung injury (ALI).”
§ The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline > 3. Results > 3.4. Antioxidant Activity of the GHK Peptide
What the sources say
- Supportedcites [42] Park, 2016, The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice, Oncotarget source
In “GHK-Cu attenuated lung damage in LPS-induced ALI in mice” (page not provided), the paper reports markedly mitigated lung pathology and a significantly reduced lung injury score in mice pretreated with GHK-Cu. It explicitly concludes that GHK-Cu had a protective effect on LPS-induced ALI. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“When tested by Howard Maibach’s group (Univerisity of California at San Francisco), 0.68% GHK-Cu was applied to dermatomed skin. Over 48 h, 136 micrograms of GHK-Cu passed through the skin per centimeter squared.”
§ The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline > 4. Possible Methods of Therapeutic Use of GHK for Nerve Diseases > 4.1. Mode of Administering GHK-Cu to Patients
What the sources say
- Partly supportedcites [101] Hostynek, 2010, Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapy, Inflamm. Res. sourceExperimental — accuracy not yet measured
The Experimental design section reports applying a 0.68% aqueous GHK-Cu solution, and Results (Table 2) reports 136.2 ± 17.5 μg/cm² in receptor fluid after 48 hours with dermatomed skin. But Table 2 identifies that measured amount as copper, not GHK-Cu; the Materials section also says concentrations are reported in terms of copper. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“CuATSM extends life in such mice by up to 25%.”
§ The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline > 3. Results > 3.2. Copper Deficiency, Dementia, and Nerve Dysfunction
What the sources say
- Partly supportedcites [41] Williams, 2016, Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD, Neurobiol. Dis. sourceExperimental — accuracy not yet measured
The Introduction reports that CuATSM extended life by 15% and 26% in two ALS mouse models, while the Results report a 16% increase in another group. The claim captures a survival benefit, but “up to 25%” does not accurately describe the paper’s figures; its continuously treated CCS-coexpressing mice survived much longer still. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This is a significant amount of GHK-Cu, and a transdermal patch of a several centimeters squared may pass therapeutically effective amounts throughout the human body [101].”
§ The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline > 4. Possible Methods of Therapeutic Use of GHK for Nerve Diseases > 4.1. Mode of Administering GHK-Cu to Patients
What the sources say
- Supportedcites [101] Hostynek, 2010, Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapy, Inflamm. Res. source
The Discussion estimates that a 10 cm² GHK-Cu patch could make 1.36 mg of copper available over 48 hours and says copper retained in the skin has the potential to become systemically available. The Conclusions describe skin permeation at a therapeutically effective dose and propose transdermal dosing. The claim’s tentative wording reflects that this is a projection from ex vivo results, not a tested patch outcome. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
29 more claims
Create a free account to see all 44 claims and to verify the 4 references still open.
- It may state two separate claims as one. 9
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While GHK is known as Cu(II)-binding molecule, we found that urocanic acid also coordinates Cu(II) ions.”
From Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate (2020) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“GHK was also found to be transported into the brain [6].”
From Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate (2020) · cites this paper as [6]
In the citing paper
“If a test system has ample Cu 2+ available, the GHK will easily obtain the necessary copper 2+ [8].”
From Skin Regenerative and Anti-Cancer Actions of Copper Peptides (2018) · cites this paper as [8]
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures
Cummings, J. L., Morstorf, T., & Zhong, K. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt269 · Cited by 1,744
Endogenous DNA damage in humans: a review of quantitative data
De Bont, R. (2004) · Mutagenesis · doi:10.1093/mutage/geh025 · Cited by 1,058
Role of Oxidative Stress in Parkinson's Disease
Hwang, O. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.11 · Cited by 835
Interleukin-18 Binding Protein
Novick, D., Kim, S.-H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., & Rubinstein, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80013-8 · Cited by 779
Antioxidant role of metallothioneins: a comparative overview.
Viarengo, A., Burlando, B., Ceratto, N., & Panfoli, I. (2000) · PubMed · Cited by 341
6 Copper Complexes Offer a Physiological Approach to Treatment of Chronic Diseases
Sorenson, J. R. J. (1989) · Progress in Medicinal Chemistry · doi:10.1016/s0079-6468(08)70246-7 · Cited by 324
Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration
Kumar, N., Gross, J. B., & Ahlskog, J. E. (2004) · Neurology · doi:10.1212/01.wnl.0000132644.52613.fa · Cited by 323
Hong, Y., Downey, T., Eu, K. W., Koh, P. K., & Cheah, P. Y. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9305-4 · Cited by 319
Oxidative Stress in Neurodegeneration
Shukla, V., Mishra, S. K., & Pant, H. C. (2011) · Advances in Pharmacological Sciences · doi:10.1155/2011/572634 · Cited by 288
Research works printed but not linked: 5
- Pickart, L. (1973). A Tripeptide from Human Serum Which Enhances the Growth of Neoplastic Hepatocytes and the Survival of Normal Hepatocytes. [Ph.D. Thesis, University of California].
- National Center of Biotechnology Information Gene, Available online: https://www.ncbi.nlm.nih.gov/gene.
- Pickart, 1983, The biological effects and mechanism of action of the plasma peptide glycyl-l-histidyl-l-lysine, Lymphokines, 8, 425
- Cherdakov, 2010, Synergetic antioxidant and reparative action of thymogen, dalargin and peptide Gly-His-Lys in tubular bone fractures, Exp. Biol. Med., 4, 15
- National Center of Biotechnology Information IL17A interleukin 17A, Available online: http://www.ncbi.nlm.nih.gov/gene/3605.
Cited by
Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals
Bagheri, S., Squitti, R., Haertlé, T., Siotto, M., & Saboury, A. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00446 · Cited by 221
Copper signalling: causes and consequences
Kardos, J., Héja, L., Simon, Á., Jablonkai, I., Kovács, R., & Jemnitz, K. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0277-3 · Cited by 213
Plascencia-Villa, G., & Perry, G. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8134 · Cited by 188
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Pickart, L., & Margolina, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071987 · Cited by 158
Self-citationCopper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
Ijaz, H. W., Wang, W., & Lang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207660 · Cited by 148
Metadata
- Authors
- Pickart, L., Vasquez-Soltero, J., & Margolina, A.
- Affiliations
- Research & Development Department, Skin Biology, 4122 Factoria Boulevard SE Suite No. 200 Bellevue, WA 98006, USA
- Corresponding author
- Pickart, Loren
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2017-02-15
- Volume
- 7
- Issue
- 2
- Pages
- 20
- ISSN
- 2076-3425 (ISSN-L)
- PMC
- PMC5332963
- OpenAlex
- W2588350914
- Cited by
- 51
- References
- 113
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 12 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 10 · 2018: 7
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Brain Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- copper-binding peptides, gene expression, neurodegeneration, cognitive decline, aging, nervous system function, Connectivity Map, anti-inflammatory activity, antioxidant activity, mesenchymal stem cells, tissue regeneration, neuroprotection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline. https://app.cochat.ai/papers/10.3390/brainsci7020020
- The paper
- Pickart, L., Vasquez-Soltero, J., & Margolina, A. (2017). The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline. Brain Sciences. https://doi.org/10.3390/brainsci7020020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.